Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Affiliation country
Publication year range
1.
Addict Biol ; 24(4): 577-589, 2019 07.
Article in English | MEDLINE | ID: mdl-29569345

ABSTRACT

Alcohol addiction is a chronic neuropsychiatric disorder that represents one of the most serious global public health problems. Yet, currently there still lacks an effective pharmacotherapy. Omega-3 polyunsaturated fatty acids (N-3 PUFAs) have exhibited beneficial effects in a variety of neurological disorders, particularly in reversing behavioral deficits and neurotoxicity induced by prenatal alcohol exposure and binge drinking. In the present study, we investigated if fish oil, which is rich in N-3 PUFAs, had beneficial effects on preventing relapse and alleviating withdrawal symptoms after chronic alcohol exposure. Our results demonstrated that fish oil significantly reduced the chronic alcohol exposure-induced aberrant dendritic morphologic changes of the medium-sized spiny neurons in the core and the shell of nucleus accumbens. This inhibited the expression of AMPAR2-lacking AMPARs and their accumulation on the post synaptic membranes of medium-sized spiny neurons and eventually alleviated withdrawal symptoms and alcohol dependence. Our study therefore suggests that N-3 PUFAs are promising for treating withdrawal symptoms and alcohol dependence.


Subject(s)
Alcoholism/pathology , Central Nervous System Depressants/pharmacology , Dendrites/drug effects , Ethanol/pharmacology , Fish Oils/pharmacology , Nucleus Accumbens/drug effects , Synapses/drug effects , Alcohol Withdrawal Seizures , Animals , Dendrites/pathology , Locomotion/drug effects , Mice , Nucleus Accumbens/cytology , Nucleus Accumbens/pathology , Receptors, AMPA/drug effects , Receptors, AMPA/metabolism , Recurrence , Synapses/pathology
2.
EBioMedicine ; 32: 50-61, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29880270

ABSTRACT

Cerebral microinfarcts have significant effects on the development of geriatric neurological disorders, including vascular dementia and Alzheimer's disease. However, little is known about the pathophysiological mechanisms involved in the evolution of microinfarcts and potential treatment and prevention against these microvascular ischemic lesions. In the present study, the "single cortical microinfarct model" generated via occluding a penetrating arteriole by femtosecond laser ablation and the "multiple diffuse microinfarcts model" induced by unilateral injection of cholesterol crystals through the internal carotid artery were established to investigate the pathophysiological mechanisms underlying the evolution of microinfarcts and the effects of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) on alleviating microinfarct burdens and functional deficits. The occlusion of a single penetrating arteriole led to a distinct cortical microinfarct, which manifested as neuronal loss and occupation of activated glial cells in the ischemic core. Using Fat-1 transgenic mice and fish oil supplements, we demonstrated that both endogenously-generated and exogenously-delivered ω-3 PUFAs significantly inhibited the activation of receptor-interacting serine/threonine protein kinases 1 (RIPK1) and its downstream apoptosis-associated proteins, mitigated cell apoptosis, and anatomically reduced the microinfarct size. The protective effects of ω-3 PUFAs against microinfarcts were further verified in a multiple diffuse microinfarcts model, where ω-3 PUFAs significantly attenuated cell apoptosis as revealed by TUNEL staining, alleviated the diffuse microinfarct burdens and remarkably improved the functional deficits as evidenced by reduced spontaneous anxiety, increased preference for the novel object, and improved hippocampal-based learning and short-term memory. Together, these findings demonstrate that enriched brain ω-3 PUFAs are effective for reducing microinfarct burdens and improving the function deficits, which support the clinical research and application of ω-3 PUFAs in the treatment or prophylaxis in vascular dementia.


Subject(s)
Alzheimer Disease/diet therapy , Cerebral Infarction/diet therapy , Dietary Supplements , Fatty Acids, Omega-3/administration & dosage , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Animals , Apoptosis/drug effects , Cadherins/genetics , Cerebral Cortex/drug effects , Cerebral Cortex/pathology , Cerebral Infarction/genetics , Cerebral Infarction/metabolism , Cerebral Infarction/pathology , Disease Models, Animal , Fish Oils/administration & dosage , Hippocampus/drug effects , Hippocampus/pathology , Humans , Mice , Mice, Transgenic , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Neuroprotective Agents/administration & dosage , Receptor-Interacting Protein Serine-Threonine Kinases/genetics
3.
Mol Neurobiol ; 54(5): 3317-3326, 2017 07.
Article in English | MEDLINE | ID: mdl-27167127

ABSTRACT

Currently no effective therapies are available for the treatment of traumatic brain injury (TBI). Early intervention that specifically provides neuroprotection is of most importance which profoundly influences the outcome of TBI. In the present study, we adopted a closed-skull mild TBI model to investigate potential roles of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) in protecting against TBI. Using two-photon laser scanning microscopy (2PLSM), parenchymal cell death and reactive oxidative species (ROS) expression were directly observed and recorded after TBI through a thinned skull bone window. Fat-1 mice with high endogenous ω-3 PUFAs significantly inhibited ROS expression and attenuated parenchymal cell death after compression injury during the early injury phase. Elevated generation of glutathione (GSH) and neuroprotectin D1 (NPD1) in the parenchyma of fat-1 mice could be the contributor to the beneficial role of ω-3 PUFAs in TBI. The results of the study suggest that ω-3 PUFAs is an effective neuroprotectant as an early pharmacological intervention for TBI and the information derived from this study may help guide dietary advice for those who are susceptible to repetitive mild TBI.


Subject(s)
Brain Injuries, Traumatic/pathology , Brain/pathology , Fatty Acids, Omega-3/metabolism , Animals , Cadherins/metabolism , Cell Death/drug effects , Docosahexaenoic Acids/metabolism , Glutathione/metabolism , Mice, Inbred C57BL , Mice, Transgenic , Reactive Oxygen Species/metabolism
4.
Mol Neurobiol ; 53(9): 6482-6488, 2016 11.
Article in English | MEDLINE | ID: mdl-26611833

ABSTRACT

Omega-3 polyunsaturated fatty acids (n-3 PUFAs) exert therapeutic potential in a variety of neurological disorders, including ischemic stroke. However, the underlying mechanisms still lack investigation. Here, we report that cultured cortical neurons isolated from fat-1 mice with high endogenous n-3 PUFAs were tolerant to oxygen-glucose deprivation/reperfusion (OGD/R) injury. Fat-1 neurons exhibited significantly attenuated reactive oxygen species (ROS) activation induced by OGD/R injury, upregulated antiapoptotic proteins Bcl-2 and Bcl-xL, and reduced cleaved caspase-3. Exogenous administration of docosahexaenoic acid (DHA), a major component of the n-3 PUFA family, resulted in similar protective effects on cultured cortex neurons. We further verified the protective effects of n-3 PUFAs in vivo, using a mini ischemic model with a reproducible cortical infarct and manifest function deficits by occlusion of the distal branch of the middle cerebral artery with focused femtosecond laser pulses. The Fat-1 animals showed decreased ROS expression and higher level of glutathione in the injured brain, associated with improved functional recovery. We therefore provide evidence that n-3 PUFAs exert their protective effects against ischemic injury both in vitro and in vivo, partly through inhibiting ROS activation.


Subject(s)
Brain Ischemia/drug therapy , Brain Ischemia/pathology , Cerebral Cortex/pathology , Fatty Acids, Omega-3/therapeutic use , Neurons/pathology , Neuroprotective Agents/therapeutic use , Animals , Brain Ischemia/physiopathology , Cadherins/metabolism , Cells, Cultured , Disease Models, Animal , Docosahexaenoic Acids/administration & dosage , Docosahexaenoic Acids/pharmacology , Docosahexaenoic Acids/therapeutic use , Fatty Acids, Omega-3/pharmacology , Female , Glucose/deficiency , Glutathione/metabolism , Mice, Inbred C57BL , Neurons/drug effects , Neurons/metabolism , Neuroprotection/drug effects , Neuroprotective Agents/pharmacology , Oxygen , Reactive Oxygen Species/metabolism , Recovery of Function/drug effects , Reperfusion Injury/drug therapy , Reperfusion Injury/pathology , Up-Regulation/drug effects
5.
J Lipid Res ; 55(7): 1288-97, 2014 07.
Article in English | MEDLINE | ID: mdl-24875538

ABSTRACT

Transient global cerebral ischemia, one of the consequences of cardiac arrest and cardiovascular surgery, usually leads to delayed death of hippocampal cornu Ammonis1 (CA1) neurons and cognitive deficits. Currently, there are no effective preventions or treatments for this condition. Omega-3 (ω-3) PUFAs have been shown to have therapeutic potential in a variety of neurological disorders. Here, we report that the transgenic mice that express the fat-1 gene encoding for ω-3 fatty acid desaturase, which leads to an increase in endogenous ω-3 PUFAs and a concomitant decrease in ω-6 PUFAs, were protected from global cerebral ischemia injury. The results of the study show that the hippocampal CA1 neuronal loss and cognitive deficits induced by global ischemia insult were significantly less severe in fat-1 mice than in WT mice controls. The protection against global cerebral ischemia injury was closely correlated with increased production of resolvin D1, suppressed nuclear factor-kappa B activation, and reduced generation of pro-inflammatory mediators in the hippocampus of fat-1 mice compared with WT mice controls. Our study demonstrates that fat-1 mice with high endogenous ω-3 PUFAs exhibit protective effects on hippocampal CA1 neurons and cognitive functions in a global ischemia injury model.


Subject(s)
Brain Ischemia/prevention & control , CA1 Region, Hippocampal/metabolism , Docosahexaenoic Acids/pharmacology , Neurons/metabolism , Animals , Brain Ischemia/genetics , Brain Ischemia/metabolism , Brain Ischemia/pathology , CA1 Region, Hippocampal/pathology , Cadherins/genetics , Cadherins/metabolism , Cognitive Dysfunction/genetics , Cognitive Dysfunction/metabolism , Cognitive Dysfunction/pathology , Cognitive Dysfunction/prevention & control , Mice , Mice, Mutant Strains , Neurons/pathology
6.
Zhong Yao Cai ; 30(2): 172-3, 2007 Feb.
Article in Chinese | MEDLINE | ID: mdl-17571766

ABSTRACT

OBJECTIVE: To explore the effect of crystal water on deteriming content of baicalin. METHODS: Baicalin samples containing different amount of crystal water were determined by HPLC. RESULTS: The determining results of baicalin were accurate and stable on condition that the samples contain some crystal water or some impurities, and the determining results of baicalin were reduced remarkably on condition that the samples are anhydrous and pure. CONCLUSION: The determining results of baicalin contents were accurate and stable only if the oxygen in 1 place forms hydrogen bond, and the determining results of baicalin contents were reduced remarkably on condition that the oxygen in 1 place forms protonated ether of form positive carbonic.


Subject(s)
Drugs, Chinese Herbal/chemistry , Flavonoids/analysis , Plants, Medicinal/chemistry , Scutellaria baicalensis/chemistry , Chromatography, High Pressure Liquid , Drugs, Chinese Herbal/standards , Flavonoids/chemistry , Hydrogen Bonding , Molecular Structure , Quality Control , Water
SELECTION OF CITATIONS
SEARCH DETAIL